Skip to content 
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company's novel understanding of the molecular mechanisms of growth factor activation within the transforming growth factor beta (TGFß) superfamily has enabled the development of a proprietary platform. This platform is used for the development of monoclonal antibodies that locally and selectively target the precursor, or latent, forms of growth factors. The company is developing Apitegromab, an inhibitor of the activation of myostatin, which is in a Phase 2 clinical trial for the treatment of SMA and facioscapulohumeral muscular dystrophy (FSHD). Additionally, SRK-439, an anti-pro/latent myostatin antibody, is in a Phase 1 clinical trial for the treatment of patients with rare, severe, and debilitating neuromuscular diseases. SRK-181 is a Phase 2-ready investigational inhibitor of latent TGFß1 for the treatment of patients with solid tumors that are resistant to anti-PD-(L)1 antibody therapies. The company also offers products in pre-clinical development, including SRK-373, a selective inhibitor of the latent TGFß1 isoform with selective activity in the fibrotic extracellular matrix, for the treatment of fibrotic diseases, and SRK-256, an inhibitor of RGMc, or hemojuvelin, for the treatment of iron-restricted anemias. Scholar Rock Holding Corporation is also developing a pipeline that includes programs for the treatment of patients with rare, severe, and debilitating neuromuscular diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts. more
| Time Frame | SRRK | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 11.57% | -2.12% | -0.38% |
| 1-Month Return | -7% | -6.51% | -4.3% |
| 3-Month Return | -1.24% | -5.6% | -3.65% |
| 6-Month Return | 37.02% | 7.3% | -1.3% |
| 1-Year Return | 32.7% | -0.27% | 16.65% |
| 3-Year Return | 388.94% | 15.48% | 67.09% |
| 5-Year Return | -26.65% | 26.75% | 67.58% |
| 10-Year Return | 188% | 118.07% | 223.2% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 18.82M | 33.19M | - | - | - | [{"date":"2021-12-31","value":56.69,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Cost of Revenue | 108.47M | 9.88M | 2.84M | 1.94M | 1.66M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":9.11,"profit":true},{"date":"2023-12-31","value":2.62,"profit":true},{"date":"2024-12-31","value":1.79,"profit":true},{"date":"2025-12-31","value":1.53,"profit":true}] |
| Gross Profit | (89.65M) | 33.19M | (2.84M) | (1.94M) | (1.66M) | [{"date":"2021-12-31","value":-270.09,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-8.57,"profit":false},{"date":"2024-12-31","value":-5.84,"profit":false},{"date":"2025-12-31","value":-5,"profit":false}] |
| Gross Margin | (476.47%) | 100.00% | - | - | - | [{"date":"2021-12-31","value":-476.47,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Operating Expenses | 40.27M | 167.56M | 168.45M | 250.12M | 382.99M | [{"date":"2021-12-31","value":10.51,"profit":true},{"date":"2022-12-31","value":43.75,"profit":true},{"date":"2023-12-31","value":43.98,"profit":true},{"date":"2024-12-31","value":65.31,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Operating Income | (129.92M) | (134.37M) | (171.29M) | (252.05M) | (384.64M) | [{"date":"2021-12-31","value":-12992000000,"profit":false},{"date":"2022-12-31","value":-13437000000,"profit":false},{"date":"2023-12-31","value":-17129500000,"profit":false},{"date":"2024-12-31","value":-25205400000,"profit":false},{"date":"2025-12-31","value":-38464500000,"profit":false}] |
| Total Non-Operating Income/Expense | - | - | - | 11.61M | 13.71M | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":84.63,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Pre-Tax Income | (131.80M) | (134.50M) | (165.79M) | (246.29M) | (377.94M) | [{"date":"2021-12-31","value":-13179900000,"profit":false},{"date":"2022-12-31","value":-13450200000,"profit":false},{"date":"2023-12-31","value":-16578900000,"profit":false},{"date":"2024-12-31","value":-24629400000,"profit":false},{"date":"2025-12-31","value":-37793900000,"profit":false}] |
| Income Taxes | 2.39M | (2.85M) | 2.68M | - | - | [{"date":"2021-12-31","value":89.33,"profit":true},{"date":"2022-12-31","value":-106.65,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income After Taxes | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | (131.80M) | (134.50M) | (158.92M) | (246.29M) | (377.94M) | [{"date":"2021-12-31","value":-13179900000,"profit":false},{"date":"2022-12-31","value":-13450200000,"profit":false},{"date":"2023-12-31","value":-15891800000,"profit":false},{"date":"2024-12-31","value":-24629400000,"profit":false},{"date":"2025-12-31","value":-37793900000,"profit":false}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | (131.80M) | (131.65M) | (165.79M) | (246.29M) | (377.94M) | [{"date":"2021-12-31","value":-13179900000,"profit":false},{"date":"2022-12-31","value":-13164800000,"profit":false},{"date":"2023-12-31","value":-16578900000,"profit":false},{"date":"2024-12-31","value":-24629400000,"profit":false},{"date":"2025-12-31","value":-37793900000,"profit":false}] |
| EPS (Diluted) | (3.59) | (2.28) | (1.99) | (2.46) | (3.43) | [{"date":"2021-12-31","value":-359,"profit":false},{"date":"2022-12-31","value":-228,"profit":false},{"date":"2023-12-31","value":-199,"profit":false},{"date":"2024-12-31","value":-246.44,"profit":false},{"date":"2025-12-31","value":-343,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
| SRRK | |
|---|---|
| Cash Ratio | 6.63 |
| Current Ratio | 6.95 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| SRRK | |
|---|---|
| ROA (LTM) | -54.69% |
| ROE (LTM) | -123.08% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| SRRK | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.39 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.61 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| SRRK | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 13.14 |
| P/B | 21.31 |
| Price/FCF | NM |
| EV/R | 8.22 |
| EV/Ebitda | NM |
Scholar Rock Holding Corp (SRRK) share price today is $44.64
Yes, Indians can buy shares of Scholar Rock Holding Corp (SRRK) on Vested. To buy
Yes, you can purchase fractional shares of Scholar Rock Holding Corp (SRRK) via the Vested app. You can start investing in Scholar Rock Holding Corp (SRRK) with a minimum investment of $1.
You can invest in shares of Scholar Rock Holding Corp (SRRK) via Vested in three simple steps:
The 52-week high price of Scholar Rock Holding Corp (SRRK) is $49.82. The 52-week low price of Scholar Rock Holding Corp (SRRK) is $22.71.
The price-to-earnings (P/E) ratio of Scholar Rock Holding Corp (SRRK) is
The price-to-book (P/B) ratio of Scholar Rock Holding Corp (SRRK) is 21.31
The dividend yield of Scholar Rock Holding Corp (SRRK) is 0.00%
The market capitalization of Scholar Rock Holding Corp (SRRK) is $5.23B
The stock symbol (or ticker) of Scholar Rock Holding Corp is SRRK
Consider the share price of Scholar Rock Holding Corp as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Scholar Rock Holding Corp has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Scholar Rock Holding Corp shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Scholar Rock Holding Corp stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Scholar Rock Holding Corp and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Scholar Rock Holding Corp stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
